Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Clinical trial NCT02210117 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02210117
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Metastatic Kidney Carcinoma Stage IV Renal Cell Cancer AJCC v7

Start date: 2014-11-25
Primary completion: 2026-12-31
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.